These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10519976)

  • 41. VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries.
    Dalsgaard T; Hannibal J; Fahrenkrug J; Larsen CR; Ottesen B
    Regul Pept; 2003 Feb; 110(3):179-88. PubMed ID: 12573798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on the cardiovascular system in sheep.
    Sawangjaroen K; Dallemagne CR; Cross RB; Curlewis JD
    Peptides; 1992; 13(5):1029-32. PubMed ID: 1480509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The neuropeptides VIP and PACAP inhibit IL-2 transcription by decreasing c-Jun and increasing JunB expression in T cells.
    Wang HY; Jiang XM; Ganea D
    J Neuroimmunol; 2000 Apr; 104(1):68-78. PubMed ID: 10683516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PACAP and VIP differentially preserve neurovascular reactivity after global cerebral ischemia in newborn pigs.
    Lenti L; Zimmermann A; Kis D; Oláh O; Tóth GK; Hegyi O; Busija DW; Bari F; Domoki F
    Brain Res; 2009 Aug; 1283():50-7. PubMed ID: 19538945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic actions of systemically injected pituitary adenylate cyclase activating polypeptide-27 in the rat.
    Whalen EJ; Johnson AK; Lewis SJ
    Eur J Pharmacol; 1999 Jan; 365(2-3):205-15. PubMed ID: 9988104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The stimulatory effect of VIP and PACAP on adrenal aldosterone release.
    Radzikowska M; Wasilewska-Dziubińska E; Baranowska B
    Ann N Y Acad Sci; 1998 Dec; 865():482-5. PubMed ID: 9928055
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of VIP and PACAP on vascular and luminal release of serotonin from isolated perfused rat duodenum.
    Fujimiya M; Yamamoto H; Kuwahara A
    Ann N Y Acad Sci; 1998 Dec; 865():495-502. PubMed ID: 9928058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo.
    Warren JB; Larkin SW; Coughlan M; Kajekar R; Williams TJ
    Br J Pharmacol; 1992 Jun; 106(2):331-4. PubMed ID: 1393266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pituitary adenylate cyclase-activating polypeptide induces hyperthermia in the rat.
    Pataki I; Adamik A; Jászberényi M; Mácsai M; Telegdy G
    Neuropharmacology; 2000 Apr; 39(7):1303-8. PubMed ID: 10760372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pituitary adenylate cyclase activating polypeptide enhances rapid eye movement sleep in rats.
    Fang J; Payne L; Krueger JM
    Brain Res; 1995 Jul; 686(1):23-8. PubMed ID: 7583267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulation of cyclic AMP formation by pituitary adenylate cyclase-activating polypeptide is attenuated by glutamate in rat brain slices.
    Kondo K; Hashimoto H; Sakata K; Saga H; Kitanaka J; Baba A
    Jpn J Pharmacol; 1995 Apr; 67(4):399-401. PubMed ID: 7650875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PACAP enhances the expression of CD11b, CD66b and CD63 in human neutrophils.
    Kinhult J; Egesten A; Uddman R; Cardell LO
    Peptides; 2002 Oct; 23(10):1735-9. PubMed ID: 12383860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pituitary adenylate cyclase-activating polypeptide dilates cerebral arterioles of newborn pigs.
    Tong S; Parfenova H; Shibata M; Zuckerman S; Armstead WM; Leffler CW
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):343-7. PubMed ID: 8390692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contractility of retinal pericytes grown on silicone elastomer substrates is through a protein kinase A-mediated intracellular pathway in response to vasoactive peptides.
    Markhotina N; Liu GJ; Martin DK
    IET Nanobiotechnol; 2007 Jun; 1(3):44-51. PubMed ID: 17506596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Region-specific regulation of neurogenesis by VIP and PACAP: direct and indirect modes of action.
    DiCicco-Bloom E
    Ann N Y Acad Sci; 1996 Dec; 805():244-56; discussion 256-8. PubMed ID: 8993407
    [No Abstract]   [Full Text] [Related]  

  • 56. Short- and long-term regulation of tyrosine hydroxylase in chromaffin cells by VIP and PACAP.
    Haycock JW
    Ann N Y Acad Sci; 1996 Dec; 805():219-30; discussion 230-1. PubMed ID: 8993405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opposing roles of cyclic AMP in the vascular control of edema formation.
    Warren JB; Wilson AJ; Loi RK; Coughlan ML
    FASEB J; 1993 Nov; 7(14):1394-400. PubMed ID: 7693536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative effects of ACTH, PACAP, and VIP on fetal human adrenal cells.
    Chamoux E; Breault L; LeHoux JG; Gallo-Payet N
    Endocr Res; 1998; 24(3-4):943-6. PubMed ID: 9888602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) stimulates rat peritoneal macrophage functions.
    Delgado M; Garrido E; de la Fuente M; Gomariz RP
    Peptides; 1996; 17(7):1097-105. PubMed ID: 8959742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pituitary adenylate cyclase-activating peptide inhibits neutrophil chemotaxis.
    Kinhult J; Uddman R; Laan M; Lindén A; Cardell LO
    Peptides; 2001 Dec; 22(12):2151-4. PubMed ID: 11786203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.